喘和肥胖中的肠肺轴:肠道微生物群的作用
Hiroki Tashiro1, Yuki Kuwahara1, Koichiro Takahashi1
1Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
肥胖会通过改变肠道微生物组而使喘恶化,影响免疫反应. 用益生菌等干预措施准肠道微生物可能为肥胖的喘患者提供新的治疗方法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 肥胖增加了喘的严重程度,但有针对性的治疗方法是有限的.
- 人们越来越认识到肠道微生物组是喘和肥胖中代谢和免疫路径之间的联系.
研究的目的:
- 审查肠道微生物组,免疫反应和喘中的肠肺轴之间的相互作用,特别是肥胖个体.
- 探索微生物组成和代谢物如何影响呼吸道炎症和高反应性.
主要方法:
- 关于研究肠道微生物组在喘和肥胖中的作用的文献综述.
- 对动物研究的分析表明微生物组操纵对喘结果的影响.
- 检查针对肠道微生物组的潜在治疗干预措施.
主要成果:
- 肥胖会改变肠道微生物群,促进全身炎症和代谢功能障碍.
- 特定的肠道微生物特征与与肥胖相关的喘表型有关.
- 在动物模型中的微生物组操纵可以改变喘的结果,特别是在肥胖症中.
结论:
- 肠道微生物组是治疗肥胖患者喘的有前途的治疗标.
- 诸如益生菌,益生菌和抗生素等干预措施显示出调节呼吸道炎症和喘严重性的潜力.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
相关概念视频
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
